ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

DC, DCR Boards Angered when NCI Ignored In AIDS Money Amendment

October 26, 1984

Prostatectomy Improves Outcome In Some Men

August 29, 2008

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

December 12, 2014

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

November 27, 2009

House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.

July 1, 2005

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012